NCT00831571View on ClinicalTrials.gov

Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2012

Study Completion Date

April 30, 2022

Conditions
Colorectal CancerEsophageal CancerGastric CancerSmall Bowel CancerPancreatic Cancer
Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER